B-lymphocytes as Targets for Therapy in Chronic Cold Agglutinin Disease

E-ISSN： 2212-4063|7|3|219-227

ISSN： 1871-529X

Source： Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol.7, Iss.3, 2007-09, pp. : 219-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Primary chronic cold agglutinin disease: An update on pathogenesis, clinical features and therapy

By Berentsen Sigbjørn Beiske Klaus Tjønnfjord Geir E.

Hematology, Vol. 12, Iss. 5, 2007-10 ,pp. : 361-370

Maney Publishing

Access to resources Recommend Favorite

Prohibitin Expression Is Increased in Phorbol Ester-Treated Chronic Leukemic B-Lymphocytes

By Woodlock T.J. Bethlendy G. Segel G.B.

Blood Cells, Molecules, and Diseases, Vol. 27, Iss. 1, 2001-01 ,pp. : 27-34

Academic Press

Access to resources Recommend Favorite

Selective silencing of disease-associated B-lymphocytes by chimeric molecules targeting their FcIIb receptor

By Mihaylova Nikolina Voynova Elisaveta Tchorbanov Andrey Nikolova Maria Michova Antoaneta Todorov Todor Srebreva Luba Taskov Hristo Vassilev Tchavdar

International Immunology, Vol. 20, Iss. 2, 2008-02 ,pp. : 165-175

Oxford University Press

Access to resources Recommend Favorite

Hepatosplenic alpha/beta T cell lymphoma presenting with cold agglutinin disease

By Minauchi Koichiro Nishio Mitsufumi Itoh Tomoo Yamamoto Satoshi Fujimoto Katsuya Sato Norihiro Koike Takao

Annals of Hematology, Vol. 86, Iss. 2, 2007-02 ,pp. : 155-157

Springer Publishing Company

Access to resources Recommend Favorite

Asbestos activates CH12.LX B-lymphocytes via macrophage signaling

By Rasmussen Devon L. Pfau Jean C.

Journal of Immunotoxicology, Vol. 9, Iss. 2, 2012-06 ,pp. : 129-140

Informa Healthcare

Access to resources Recommend Favorite